124 related articles for article (PubMed ID: 38686760)
1. Letter to the Editor: Outcomes of patients with an intermediate risk group according to the Japanese risk classification of papillary thyroid carcinoma.
Kumari M; Chand G
World J Surg; 2024 Jan; 48(1):250. PubMed ID: 38686760
[No Abstract] [Full Text] [Related]
2. Authors' response: Outcomes of patients with an intermediate-risk group according to the Japanese risk classification of papillary thyroid carcinoma.
Horiuchi K
World J Surg; 2024 Jan; 48(1):251. PubMed ID: 38686772
[No Abstract] [Full Text] [Related]
3. Outcomes of Patients with an Intermediate-Risk Group According to the Japanese Risk Classification of Papillary Thyroid Carcinoma.
Horiuchi K; Fujimoto M; Hidenori K; Yoshida Y; Noguchi E; Omi Y; Okamoto T
World J Surg; 2023 Oct; 47(10):2464-2473. PubMed ID: 37266697
[TBL] [Abstract][Full Text] [Related]
4. Subset analysis of the Japanese risk classification guidelines for papillary thyroid carcinoma.
Ito Y; Miyauchi A; Yamamoto M; Masuoka H; Higashiyama T; Kihara M; Miya A
Endocr J; 2020 Mar; 67(3):275-282. PubMed ID: 31776303
[TBL] [Abstract][Full Text] [Related]
5. Reply to a Letter to the Editor: can we really consider tumor size and surgical extent as predictive factors for recurrence in clinically early-stage papillary thyroid carcinoma patients?
Roh JL; Kim JW
Am J Surg; 2016 Nov; 212(5):1031-1032. PubMed ID: 27523924
[No Abstract] [Full Text] [Related]
6. De-differentiation of papillary thyroid carcinoma into squamous cell carcinoma in an elderly patient: A case report.
Thewjitcharoen Y; Krittiyawong S; Butadej S; Nakasatien S; Polchart S; Junyangdikul P; Kanchanapituk A; Himathongkam T
Medicine (Baltimore); 2020 Apr; 99(16):e19892. PubMed ID: 32312017
[TBL] [Abstract][Full Text] [Related]
7. Transglottic intralaryngeal papillary thyroid carcinoma.
Varghese BT; Nair SP; Janardhan D
Oral Oncol; 2022 Aug; 131():105935. PubMed ID: 35671688
[TBL] [Abstract][Full Text] [Related]
8. Thyroidectomy vs Active Surveillance for Subcentimeter Papillary Thyroid Cancers--The Cost Conundrum.
Kandil E; Noureldine SI; Tufano RP
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):9-10. PubMed ID: 26661274
[No Abstract] [Full Text] [Related]
9. Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
Heo DB; Won HR; Tae K; Kang YE; Jeon E; Ji YB; Chang JW; Choi JY; Yu HW; Ku EJ; Lee EK; Kim M; Choe JH; Koo BS;
Surgery; 2024 Apr; 175(4):1049-1054. PubMed ID: 38281855
[TBL] [Abstract][Full Text] [Related]
10. Letter to the Editor regarding, "Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis".
Yu ST; Xiao ZZ
Oral Oncol; 2019 Apr; 91():132-133. PubMed ID: 30773348
[No Abstract] [Full Text] [Related]
11. Metastatic hobnail variant of papillary thyroid carcinoma: A diagnostic challenge in cell block preparation.
Mohapatra D; Naik S; Das P; Agrawala S
Indian J Pathol Microbiol; 2021; 64(2):358-361. PubMed ID: 33851635
[TBL] [Abstract][Full Text] [Related]
12. Current trends in TSH suppression therapy for patients with papillary thyroid carcinoma in Japan: results of a questionnaire distributed to councilors of the Japanese Society of Thyroid Surgery.
Tanaka K; Sonoo H
Surg Today; 2012 Jul; 42(7):633-8. PubMed ID: 22173648
[TBL] [Abstract][Full Text] [Related]
13. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
15. Letter to the Editor: "An Analysis of the American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma".
Asare EA; Perrier ND
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 31665320
[No Abstract] [Full Text] [Related]
16. Effect of prophylactic central neck dissection following total thyroidectomy on surgical site wound infection, hematoma, and haemorrhage in subjects with clinically node-negative papillary thyroid carcinoma: A meta-analysis.
Jin L; Liu L; Wang J; Zhang L
Int Wound J; 2023 Feb; 20(2):251-260. PubMed ID: 35702946
[TBL] [Abstract][Full Text] [Related]
17. A rare coexistence of thyroid lymphoma with papillary thyroid carcinoma.
Cakir M; Celik E; Tuncer FB; Tekin A
Ann Afr Med; 2013; 12(3):188-90. PubMed ID: 24005594
[TBL] [Abstract][Full Text] [Related]
18. Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.
Bogdanova TI; Saenko VA; Hirokawa M; Ito M; Zurnadzhy LY; Hayashi T; Rogounovitch TI; Miyauchi A; Tronko MD; Yamashita S
Endocr J; 2017 Oct; 64(10):977-993. PubMed ID: 28794343
[TBL] [Abstract][Full Text] [Related]
19. [Clinical treatment of metastatic papillary thyroid carcinoma in cervical lymph nodal with occult primary sites].
Pang YJ; Chen XH; Zhang JY; Gao JL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(13):1013-1016. PubMed ID: 29798166
[No Abstract] [Full Text] [Related]
20. Appropriateness of the revised Japanese guidelines' risk classification for the prognosis of papillary thyroid carcinoma: a retrospective analysis of 5,845 papillary thyroid carcinoma patients.
Ito Y; Miyauchi A; Oda H; Masuoka H; Higashiyama T; Kihara M; Miya A
Endocr J; 2019 Feb; 66(2):127-134. PubMed ID: 30626761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
